Tarek Alsaied1, Jouke P Bokma2,3, Mark E Engel4, Joey M Kuijpers2,3, Samuel P Hanke1, Liesl Zuhlke5, Bin Zhang6, Gruschen R Veldtman7. 1. Children's Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. 2. Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands. 3. The Netherlands Interuniversity Cardiology Institute of the Netherlands-Netherlands Heart Institute, Utrecht, The Netherlands. 4. Department of Medicine, Groote Schuur Hospital, Cape Town, South Africa. 5. Department of Paediatrics, Red Cross War Memorial Children's Hospital and University of Cape Town, Cape Town, South Africa. 6. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio USA. 7. Adolescent and Adult Congenital Program, Children's Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Abstract
BACKGROUND: Despite an ageing Fontan population, data on late outcomes are still scarce. Reported outcome measures and determinants vary greatly between studies making comprehensive appraisal of mortality hazard challenging. METHODS: We conducted a systematic review to evaluate causes and factors associated with late mortality in patients with Fontan circulation. Late mortality was defined as mortality beyond the first postoperative year. Studies were included if they had ≥90 patients or ≥20 late mortalities and/or transplants. Studies with overlapping patients were rationalised to include only the most recent studies to avoid duplication. RESULTS: From 28 studies, a total of 6707 patients with an average follow-up time of 8.23±5.42 years was identified. There were 1000 deaths. Causes of late death were reported in 697 cases. The five most common causes were heart/Fontan failure (22%), arrhythmia (16%), respiratory failure (15%), renal disease (12%) and thrombosis/bleeding (10%). Factors associated with late mortality were evaluated and classified into 9 categories. CONCLUSIONS: Causes and factors associated with late mortality after the Fontan operation are summarised in this study. The presented information will aid in identifying patients at highest risk for mortality and guide our risk stratification efforts in this patient population. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: Despite an ageing Fontan population, data on late outcomes are still scarce. Reported outcome measures and determinants vary greatly between studies making comprehensive appraisal of mortality hazard challenging. METHODS: We conducted a systematic review to evaluate causes and factors associated with late mortality in patients with Fontan circulation. Late mortality was defined as mortality beyond the first postoperative year. Studies were included if they had ≥90 patients or ≥20 late mortalities and/or transplants. Studies with overlapping patients were rationalised to include only the most recent studies to avoid duplication. RESULTS: From 28 studies, a total of 6707 patients with an average follow-up time of 8.23±5.42 years was identified. There were 1000 deaths. Causes of late death were reported in 697 cases. The five most common causes were heart/Fontan failure (22%), arrhythmia (16%), respiratory failure (15%), renal disease (12%) and thrombosis/bleeding (10%). Factors associated with late mortality were evaluated and classified into 9 categories. CONCLUSIONS: Causes and factors associated with late mortality after the Fontan operation are summarised in this study. The presented information will aid in identifying patients at highest risk for mortality and guide our risk stratification efforts in this patient population. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Anita Saraf; Christine De Staercke; Ian Everitt; Alice Haouzi; Yi-An Ko; Staci Jennings; Jonathan H Kim; Fred H Rodriguez; Andreas P Kalogeropoulos; Arshed Quyyumi; Wendy Book Journal: Int J Cardiol Date: 2020-01-09 Impact factor: 4.164
Authors: Alexander C Egbe; Yogesh N V Reddy; Arooj R Khan; Mohamad Al-Otaibi; Emmanuel Akintoye; Masaru Obokata; Barry A Borlaug Journal: Int J Cardiol Date: 2018-11-15 Impact factor: 4.164
Authors: C G Stevens; J Kay; K Pickett; K Campbell; A D Khanna; E Yeung; S D Miyamoto; R M Jacobsen Journal: Pediatr Cardiol Date: 2021-06-18 Impact factor: 1.655
Authors: Aaron W Eckhauser; Maria I Van Rompay; Chitra Ravishankar; Jane W Newburger; S Ram Kumar; Christian Pizarro; Nancy Ghanayem; Felicia L Trachtenberg; Kristin M Burns; Garick D Hill; Andrew M Atz; Michelle S Hamstra; Mjaye Mazwi; Patsy Park; Marc E Richmond; Michael Wolf; Jeffrey D Zampi; Jeffrey P Jacobs; L LuAnn Minich Journal: Cardiol Young Date: 2019-11-26 Impact factor: 1.093
Authors: Michael L O'Byrne; Jennifer A Faerber; Hannah Katcoff; Jing Huang; Jonathan B Edelson; David M Finkelstein; Bethan A Lemley; Christopher M Janson; Catherine M Avitabile; Andrew C Glatz; David J Goldberg Journal: Am Heart J Date: 2021-09-25 Impact factor: 4.749
Authors: Susan R Hopkins; Rui C Sá; G Kim Prisk; Ann R Elliott; Nick H Kim; Beni J Pazar; Beth F Printz; Howaida G El-Said; Christopher K Davis; Rebecca J Theilmann Journal: J Physiol Date: 2020-10-27 Impact factor: 5.182